BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8154343)

  • 1. Biophysical studies of interactions of hirudin analogs with bovine and human thrombin by ESR and fluorescence labelling studies.
    Berliner LJ; Woodford JK
    Adv Exp Med Biol; 1993; 340():51-65. PubMed ID: 8154343
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural differences in active site-labeled thrombin complexes with hirudin isoinhibitors.
    Rowand JK; Berliner LJ
    J Protein Chem; 1992 Oct; 11(5):483-8. PubMed ID: 1333213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of a complex of bovine alpha-thrombin and recombinant hirudin at 2.8-A resolution.
    Vitali J; Martin PD; Malkowski MG; Robertson WD; Lazar JB; Winant RC; Johnson PH; Edwards BF
    J Biol Chem; 1992 Sep; 267(25):17670-8. PubMed ID: 1517214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of fluorescent and spin-labeled C-terminal hirudin analogs to thrombin.
    Sankarapandi S; Woodford JK; Krstenansky JL; Berliner LJ
    J Med Chem; 1994 Oct; 37(22):3855-8. PubMed ID: 7966143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermodynamic investigation of hirudin binding to the slow and fast forms of thrombin: evidence for folding transitions in the inhibitor and protease coupled to binding.
    Ayala YM; Vindigni A; Nayal M; Spolar RS; Record MT; Di Cera E
    J Mol Biol; 1995 Nov; 253(5):787-98. PubMed ID: 7473752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin-bound conformation of a cyclic anticoagulant peptide using transferred nuclear Overhauser effect (NOE), distance geometry, and NOE simulations.
    Ning Q; Ripoll DR; Szewczuk Z; Konishi Y; Ni F
    Biopolymers; 1994 Sep; 34(9):1125-37. PubMed ID: 7948726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the hirugen and hirulog 1 complexes of alpha-thrombin.
    Skrzypczak-Jankun E; Carperos VE; Ravichandran KG; Tulinsky A; Westbrook M; Maraganore JM
    J Mol Biol; 1991 Oct; 221(4):1379-93. PubMed ID: 1942057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin.
    Johnson PH; Sze P; Winant RC; Hudson D; Underhill P; Lazar JB; Olsen C; Almquist R
    Haemostasis; 1991; 21 Suppl 1():41-8. PubMed ID: 1894196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of the thrombin des-ETW conformation by using site-directed mutants of hirudin. Evidence for the induction of nonlocal modifications by mutagenesis.
    Le Bonniec BF; Betz A; Guinto ER; Esmon CT; Stone SR
    Biochemistry; 1994 Apr; 33(13):3959-66. PubMed ID: 8142400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure of a complex of recombinant hirudin and human alpha-thrombin.
    Rydel TJ; Ravichandran KG; Tulinsky A; Bode W; Huber R; Roitsch C; Fenton JW
    Science; 1990 Jul; 249(4966):277-80. PubMed ID: 2374926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrostatic steering and ionic tethering in the formation of thrombin-hirudin complexes: the role of the thrombin anion-binding exosite-I.
    Myles T; Le Bonniec BF; Betz A; Stone SR
    Biochemistry; 2001 Apr; 40(16):4972-9. PubMed ID: 11305913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in interactions in complexes of hirudin derivatives and human alpha-thrombin due to different crystal forms.
    Priestle JP; Rahuel J; Rink H; Tones M; Grütter MG
    Protein Sci; 1993 Oct; 2(10):1630-42. PubMed ID: 8251938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of interactions with the core domain of hirudin to the stability of its complex with thrombin.
    Betz A; Hopkins PC; Le Bonniec BF; Stone SR
    Biochem J; 1994 Mar; 298 ( Pt 2)(Pt 2):507-10. PubMed ID: 8135762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of hirudin-based inhibitor with thrombin: critical role of the IleH59 side chain of the inhibitor.
    Tsuda Y; Szewczuk Z; Wang J; Yue SY; Purisima E; Konishi Y
    Biochemistry; 1995 Jul; 34(27):8708-14. PubMed ID: 7612610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant hirudin: genetic engineering and structure analysis.
    Märki WE; Grossenbacher H; Grütter MG; Liersch MH; Meyhack B; Heim J
    Semin Thromb Hemost; 1991 Apr; 17(2):88-93. PubMed ID: 1771417
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction of site specific hirudin variants with alpha-thrombin.
    Dodt J; Köhler S; Baici A
    FEBS Lett; 1988 Feb; 229(1):87-90. PubMed ID: 3345842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Glu(192) in the allosteric control of the S(2)' and S(3)' subsites of thrombin.
    Marque PE; Spuntarelli R; Juliano L; Aiach M; Le Bonniec BF
    J Biol Chem; 2000 Jan; 275(2):809-16. PubMed ID: 10625611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the hirulog 3-thrombin complex and nature of the S' subsites of substrates and inhibitors.
    Qiu X; Padmanabhan KP; Carperos VE; Tulinsky A; Kline T; Maraganore JM; Fenton JW
    Biochemistry; 1992 Dec; 31(47):11689-97. PubMed ID: 1445905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of the fluorescent amino acid 7-azatryptophan into the core domain 1-47 of hirudin as a probe of hirudin folding and thrombin recognition.
    De Filippis V; De Boni S; De Dea E; Dalzoppo D; Grandi C; Fontana A
    Protein Sci; 2004 Jun; 13(6):1489-502. PubMed ID: 15152084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ionic interactions in the formation of the thrombin-hirudin complex.
    Betz A; Hofsteenge J; Stone SR
    Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):801-3. PubMed ID: 1674862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.